Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Anne Winther‐Larsen"'
Autor:
Andreas Glenthøj, Andreas Ørslev Rasmussen, Selma Kofoed Bendtsen, Henrik Hasle, Marianne Hoffmann, Klaus Rieneck, Morten Hanefeld Dziegiel, Lene Dissing Sjö, Henrik Frederiksen, Dennis Lund Hansen, Daniel El Fassi, Mathias Rathe, Peter-Diedrich Matthias Jensen, Anne Winther-Larsen, Christian Nielsen, Marianne Olsen, Nina Toft, Mads Okkels Birk Lorenzen, Lise Heilmann Jensen, Sif Gudbrandsdottir, Jens Helby, Maria Rossing, Richard van Wijk, Jesper Petersen
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 19, Iss 1, Pp 1-11 (2024)
Abstract Background Hereditary anemias are a group of genetic diseases prevalent worldwide and pose a significant health burden on patients and societies. The clinical phenotype of hereditary anemias varies from compensated hemolysis to life-threaten
Externí odkaz:
https://doaj.org/article/571fe371a8f54ba6b50bfb5757c53faf
Publikováno v:
eJHaem, Vol 4, Iss 1, Pp 18-25 (2023)
Abstract When screening for α‐thalassemia in children, adult cut‐offs for mean corpuscular volume (MCV) and mean corpuscular hemoglobin (MCH) are generally applied to guide genetic evaluation. However, the normal ranges for MCV and MCH are lower
Externí odkaz:
https://doaj.org/article/bf69938d5a6a443c8162db36f85420e0
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Inflammation-scores based on general inflammation markers are suggested as prognostic markers of overall survival (OS) in lung cancer. However, whether these inflammation-scores improves the prognostication performed by well-estab
Externí odkaz:
https://doaj.org/article/2c5462ad7f0844dd9317b2f409acfc35
Publikováno v:
Systematic Reviews, Vol 10, Iss 1, Pp 1-14 (2021)
Abstract Background Inflammation scores based on general inflammation markers as leucocyte count or C-reactive protein have been evaluated as prognostic markers of inferior survival in several cancers. In small cell lung cancer (SCLC), however, infla
Externí odkaz:
https://doaj.org/article/62cec2fdbe7840098052bc66cd5e0ed9
Publikováno v:
EBioMedicine, Vol 49, Iss , Pp 284-290 (2019)
Background: Numerous studies have shown that cell-free DNA (cfDNA) levels may serve as a non-invasive biomarker of a broad spectrum of acute and chronic pathologies. However, in order to make clinical decisions based on cfDNA measurements, it is esse
Externí odkaz:
https://doaj.org/article/9426b61909b04628aad5f225c53004e7
Autor:
Anne Winther-Larsen, Joan Fledelius, Christina Demuth, Catharina M Bylov, Peter Meldgaard, Boe S Sorensen
Publikováno v:
Translational Oncology, Vol 9, Iss 6, Pp 505-511 (2016)
INTRODUCTION: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are a treatment option in the second- or third-line palliative setting in EGFR wild-type (wt) non–small cell lung cancer (NSCLC) patients. However, response rat
Externí odkaz:
https://doaj.org/article/49897c0d851446e0834894c40da56832
Publikováno v:
Larsen, A W, Madsen, A T, Nissen, P H, Hoffmann-Lücke, E & Greibe, E 2023, ' Short-term biological variation of plasma uracil in a Caucasian healthy population ', Clinical Chemistry and Laboratory Medicine .
Objectives Plasma uracil is a new biomarker to assess the activity of dihydropyrimidine dehydrogenase before cancer treatment with fluoropyrimidine drugs. Knowledge on the biological variation of plasma uracil is important to assess the applicability
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dad48fcd61ffb5b0f83534551b54e896
https://doi.org/10.1515/cclm-2022-1167
https://doi.org/10.1515/cclm-2022-1167
Autor:
Linda Aagaard Rasmussen, Niels Lyhne Christensen, Anne Winther-Larsen, Susanne Oksbjerg Dalton, Line Flytkjær Virgilsen, Henry Jensen, Peter Vedsted
Publikováno v:
Clinical Epidemiology.
Linda Aagaard Rasmussen,1 Niels Lyhne Christensen,2 Anne Winther-Larsen,3 Susanne Oksbjerg Dalton,4,5 Line Flytkjær Virgilsen,1 Henry Jensen,1 Peter Vedsted1 1Research Unit for General Practice, Aarhus, Denmark; 2Department of Pulmonary Medicine a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a7c28240725eb78986615d204c00535
https://www.dovepress.com/a-validated-register-based-algorithm-to-identify-patients-diagnosed--2-peer-reviewed-fulltext-article-CLEP
https://www.dovepress.com/a-validated-register-based-algorithm-to-identify-patients-diagnosed--2-peer-reviewed-fulltext-article-CLEP
Publikováno v:
Paulsen, B S, Aggerholm-Pedersen, N & Larsen, A W 2023, ' Pretreatment platelet count is a prognostic marker in lung cancer: A Danish registry-based cohort study ', Clinical Lung Cancer, vol. 24, no. 2, pp. 175-183 . https://doi.org/10.1016/j.cllc.2022.12.012
Background: Thrombocytosis has been associated with a poor prognosis in a wide range of malignancies. However, the results have been conflicting for lung cancer. Therefore, we evaluated the prognostic value of platelet count in a large cohort of lung
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d13488b47f885388664461502b602e0
https://pure.au.dk/portal/da/publications/pretreatment-platelet-count-is-a-prognostic-marker-in-lung-cancer(9b72da7d-0a1c-4225-a7fe-7724b857cbe7).html
https://pure.au.dk/portal/da/publications/pretreatment-platelet-count-is-a-prognostic-marker-in-lung-cancer(9b72da7d-0a1c-4225-a7fe-7724b857cbe7).html
Autor:
Silje Hovden Christensen, Claus Vinter Bødker Hviid, Anne Tranberg Madsen, Tina Parkner, Anne Winther-Larsen
Publikováno v:
Christensen, S H, Hviid, C V B, Madsen, A T, Parkner, T & Winther-Larsen, A 2022, ' Short-term biological variation of serum glial fibrillary acidic protein ', Clinical Chemistry and Laboratory Medicine, vol. 60, no. 11, pp. 1813-1819 . https://doi.org/10.1515/cclm-2022-0480
Hoveden Christensen, S, Hviid, C V B, Madsen, A T, Parkner, T & Larsen, A W 2022, ' Short-term biological variation of serum glial fibrillary acidic protein ', Clinical Chemistry and Laboratory Medicine, vol. 60, no. 11, pp. 1813-1819 . https://doi.org/10.1515/cclm-2022-0480
Hoveden Christensen, S, Hviid, C V B, Madsen, A T, Parkner, T & Larsen, A W 2022, ' Short-term biological variation of serum glial fibrillary acidic protein ', Clinical Chemistry and Laboratory Medicine, vol. 60, no. 11, pp. 1813-1819 . https://doi.org/10.1515/cclm-2022-0480
Objectives Serum glial fibrillary acidic protein (GFAP) is an emerging biomarker for intracerebral diseases and is approved for clinical use in traumatic brain injury. GFAP is also being investigated for several other applications, where the GFAP cha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a9298de0f1065911b23d355eaa568a3
https://vbn.aau.dk/da/publications/4420a5b2-4784-4c77-8726-74b8a6c982f3
https://vbn.aau.dk/da/publications/4420a5b2-4784-4c77-8726-74b8a6c982f3